Evidence map›Paper›PMID 30869640›Full record

ArticleJMIR cancer2019

Exploring the Experiences of Cancer Patients With Chemotherapy-Induced Ototoxicity: Qualitative Study Using Online Health Care Forums.

Stephanie E Pearson, John Taylor, Derek J Hoare, Poulam Patel, David M Baguley

Open access · goldAbstract read
In one paragraph

Article in JMIR cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. AI based sentiment analysis of online discussions related to cervical brachytherapy.Technical innovations & patient support in radiation oncology · 2025
    Article
  4. Article
  5. Use and impact of virtual resources for peer support by young adults living with cancer: A systematic review.Canadian oncology nursing journal = Revue canadienne de nursing oncologique · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Stephanie E PearsonNottingham Biomedical Research Centre, National Institute for Health Research, Nottingham, United Kingdom.ORCID http://orcid.org/0000-0001-5488-5789
John TaylorNottingham Biomedical Research Centre, National Institute for Health Research, Nottingham, United Kingdom.ORCID http://orcid.org/0000-0003-1402-1067
Derek J HoareNottingham Biomedical Research Centre, National Institute for Health Research, Nottingham, United Kingdom.ORCID http://orcid.org/0000-0002-8768-1392
Poulam PatelNottingham University Hospitals NHS Trust, Nottingham, United Kingdom.ORCID http://orcid.org/0000-0002-1978-4066
David M BaguleyNottingham Biomedical Research Centre, National Institute for Health Research, Nottingham, United Kingdom.ORCID http://orcid.org/0000-0002-0767-0723
National Health Service · GBUniversity of Nottingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMany cancer patients and survivors experience permanent and life-debilitating effects, such as ototoxicity, from treatment. Ototoxicity manifests as high-frequency hearing loss and tinnitus, which can have a detrimental effect on the quality of life (QoL) of those affected. Currently, there is little information and support offered to these patients who experience ototoxicity, potentially leading to many being undiagnosed and untreated.

objectiveThe aim of this study was to explore the extent of ototoxic side effects, such as hearing loss and tinnitus, and their impact on cancer patients following chemotherapy treatment. Secondary objectives included detecting the time periods of onset and duration of the ototoxicity and identifying what support was available to this population.

methodsPosts from publicly available online forums were thematically analyzed using the guidelines by Braun and Clarke. A coding manual was iteratively developed to create a framework for the analysis of the ototoxicity experience among the cancer population.

resultsA total of 9 relevant online forums were identified, consisting of 86 threads and 570 posts from 377 members. Following the bottom-up thematic analysis, 6 major themes were identified: nature of ototoxicity, time of experienced ototoxicity, information on ototoxicity, quality of life, therapies, and online social support.

conclusionsThere was a significant number of reports expressing concerns about the lack of information on the risk of ototoxicity. More support for those suffering is needed; for example, improved interdepartmental communication between oncology and audiology services could optimize patient care. Patients should also be encouraged to communicate with their health care professionals about their ototoxicity and relay how their QoL is impacted by ototoxicity when accessing support. Tinnitus was the most common concern and was associated with distress. Hearing loss was less common; however, it was associated with fear and employment issues. Those who reported preexisting conditions were fearful about worsening their condition as their QoL was already impacted.

Indexed as

drug-related side effects and adverse reactionseHealthhearing lossinternetneoplasmsonline social networkingquality of lifesocial supporttinnitus

Identifiers

PMID30869640
PMCPMC6437618
OpenAlexW2900645200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.